acetylcysteine has been researched along with n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doroshow, JH | 1 |
| Dear, J | 1 |
| Ignarro, LJ; Jynge, P; Karlsson, JOG; Lundström, I | 1 |
| Black, P; Dear, JW; Gallagher, B; Grahamslaw, J; Henriksen, D; Lee, RJ; Morrison, EE; O'Brien, R; Oatey, K; Oosthuyzen, W; Weir, CJ | 1 |
| Karlsson, JOG | 1 |
| Dear, JW | 1 |
| Freeman, WE; Mullins, ME; Yeager, LH | 1 |
| Akakpo, JY; Jaeschke, H; Ramachandran, A | 1 |
2 review(s) available for acetylcysteine and n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid
| Article | Year |
|---|---|
Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review.
Topics: Acetaminophen; Acetylcysteine; Acidosis; Animals; Antidotes; Cimetidine; Drug Overdose; Edetic Acid; Fomepizole; Humans; Mitochondria; Pyridoxal Phosphate | 2020 |
Novel strategies for the treatment of acetaminophen hepatotoxicity.
Topics: Acetaminophen; Acetylcysteine; Animals; Antidotes; Chemical and Drug Induced Liver Injury; Drug Overdose; Edetic Acid; Fomepizole; Hepatocytes; Humans; Liver Failure, Acute; Pyridoxal Phosphate | 2020 |
2 trial(s) available for acetylcysteine and n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid
| Article | Year |
|---|---|
Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomi
Topics: Acetaminophen; Acetylcysteine; Chemical and Drug Induced Liver Injury; Clinical Trials Data Monitoring Committees; Clinical Trials, Phase I as Topic; Data Interpretation, Statistical; Drug Overdose; Drug Therapy, Combination; Edetic Acid; Female; Humans; Male; Outcome Assessment, Health Care; Pyridoxal Phosphate; Randomized Controlled Trials as Topic; Research Design | 2019 |
Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).
Topics: Acetaminophen; Acetylcysteine; Adult; Biomarkers; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Overdose; Edetic Acid; Female; Humans; Male; Protective Agents; Pyridoxal Phosphate; Time Factors; Young Adult | 2019 |
4 other study(ies) available for acetylcysteine and n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid
| Article | Year |
|---|---|
Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity.
Topics: Acetylcysteine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Edetic Acid; Humans; Hydrogen Peroxide; Leukocytes; Mice; Oxidation-Reduction; Pyridoxal Phosphate; Reactive Oxygen Species | 2006 |
Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: stud
Topics: Acetaminophen; Acetylcysteine; Drug Overdose; Edetic Acid; Humans; Pyridoxal Phosphate; Research Design | 2019 |
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir?
Topics: Acetaminophen; Acetylcysteine; Edetic Acid; Humans; Pyridoxal Phosphate; Superoxide Dismutase | 2019 |
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' reply.
Topics: Acetaminophen; Acetylcysteine; Edetic Acid; Humans; Pyridoxal Phosphate; Superoxide Dismutase | 2019 |